Hiroshi Tanabe

机构：Jikei University School of Medicine, National Cancer Center Hospital East · ORCID：0000-0002-1301-719X

发表论文 110 篇 · 总被引 1003 次 · h-index 17

代表论文

• Neoadjuvant combination treatment of olaparib and pembrolizumab for patients with HRD-positive advanced ovarian cancer. (2024 · Journal of Clinical Oncology · 被引 8)
• A retrospective study of dose-dense paclitaxel and carboplatin plus bevacizumab as first-line treatment of advanced epithelial ovarian cancer (2024 · Journal of Gynecologic Oncology · 被引 4)
• Re-administration of platinum-based chemotherapy for recurrent endometrial cancer: an ancillary analysis of the SGSG-012/GOTIC-004/Intergroup study (2024 · International Journal of Clinical Oncology · 被引 3)
• Hemostasis of small-intestinal diverticular bleeding with the over-the-scope clip method (2023 · Endoscopy · 被引 3)
• The detrimental impact of diverting ileostomy on renal function after tumor debulking surgery for advanced ovarian cancer (2025 · Gynecologic Oncology · 被引 2)
• Short- and long-term morbidity of total parietal peritonectomy for advanced ovarian cancer (2023 · International Journal of Gynecological Cancer · 被引 2)